Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer.
Morawitz J, Kirchner J, Martin O, Bruckmann NM, Dietzel F, Li Y, Rischpler C, Herrmann K, Umutlu L, Bittner AK, Mohrmann S, Ingenwerth M, Häberle L, Esposito I, Antoch G, Buchbender C, Sawicki LM. Morawitz J, et al. Among authors: ingenwerth m. Clin Nucl Med. 2021 Mar 1;46(3):201-205. doi: 10.1097/RLU.0000000000003488. Clin Nucl Med. 2021. PMID: 33351505
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI.
Kirchner J, Grueneisen J, Martin O, Oehmigen M, Quick HH, Bittner AK, Hoffmann O, Ingenwerth M, Catalano OA, Heusch P, Buchbender C, Forsting M, Antoch G, Herrmann K, Umutlu L. Kirchner J, et al. Among authors: ingenwerth m. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2328-2337. doi: 10.1007/s00259-018-4102-4. Epub 2018 Jul 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 30056547
Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer.
Kirchner J, Sawicki LM, Nensa F, Schaarschmidt BM, Reis H, Ingenwerth M, Bogner S, Aigner C, Buchbender C, Umutlu L, Antoch G, Herrmann K, Heusch P. Kirchner J, et al. Among authors: ingenwerth m. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):437-445. doi: 10.1007/s00259-018-4109-x. Epub 2018 Aug 3. Eur J Nucl Med Mol Imaging. 2019. PMID: 30074073 Clinical Trial.
Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients.
Bruckmann NM, Sawicki LM, Kirchner J, Martin O, Umutlu L, Herrmann K, Fendler W, Bittner AK, Hoffmann O, Mohrmann S, Dietzel F, Ingenwerth M, Schaarschmidt BM, Li Y, Kowall B, Stang A, Antoch G, Buchbender C. Bruckmann NM, et al. Among authors: ingenwerth m. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2816-2825. doi: 10.1007/s00259-020-04801-2. Epub 2020 Apr 24. Eur J Nucl Med Mol Imaging. 2020. PMID: 32333068 Free PMC article.
Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?
Martin O, Bruckmann NM, Kirchner J, Ullrich T, Ingenwerth M, Bogner S, Eze C, Nensa F, Herrmann K, Umutlu L, Antoch G, Sawicki LM. Martin O, et al. Among authors: ingenwerth m. J Med Imaging Radiat Oncol. 2020 Dec;64(6):779-786. doi: 10.1111/1754-9485.13087. Epub 2020 Jul 24. J Med Imaging Radiat Oncol. 2020. PMID: 32705779
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid 68Ga-DOTATOC PET/MRI.
Bruckmann NM, Rischpler C, Kirchner J, Umutlu L, Herrmann K, Ingenwerth M, Theurer S, Lahner H, Antoch G, Sawicki LM. Bruckmann NM, et al. Among authors: ingenwerth m. Eur J Radiol. 2021 Apr;137:109588. doi: 10.1016/j.ejrad.2021.109588. Epub 2021 Feb 19. Eur J Radiol. 2021. PMID: 33639542
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients.
Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Antke C, Schimmöller L, Ingenwerth M, Breuckmann K, Stang A, Buchbender C, Antoch G, Sawicki LM. Bruckmann NM, et al. Among authors: ingenwerth m. Eur Radiol. 2021 Nov;31(11):8714-8724. doi: 10.1007/s00330-021-07956-0. Epub 2021 Apr 28. Eur Radiol. 2021. PMID: 33912991 Free PMC article.
Determining the axillary nodal status with four current imaging modalities including 18F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard.
Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, Mohrmann S, Haeberle L, Ingenwerth M, Umutlu L, Fendler WP, Fehm T, Herrmann K, Antoch G, Sawicki LM, Kirchner J. Morawitz J, et al. Among authors: ingenwerth m. J Nucl Med. 2021 May 20;62(12):1677-83. doi: 10.2967/jnumed.121.262009. Online ahead of print. J Nucl Med. 2021. PMID: 34016726 Free PMC article.
39 results